Annie Sasco

Annie J. J. Sasco is currently a Team Leader of Epidemiology for Cancer Prevention in an Inserm (NIH) Research Unit at the Medical School of the Victor Segalen Bordeaux 2 University in France. After having been trained in the Bordeaux Medical School, she went to Harvard where she got two masters and a doctoral degree in epidemiology, being for a while Teaching Fellow of Harvard University. She then worked for 22 years at the International Agency for Research on Cancer in Lyon, France, including 9 years as Group Leader and then Unit Chief of Epidemiology for Cancer Prevention. The IARC is the specialized World Health Organization agency dealing with cancer research. Dr. Sasco is a European expert on the human health effects of growth promoters used in animal husbandry. She also holds a Visiting Professorship appointment at the University of Sao Paulo, Brazil. Having been described as an “over graduated” woman, she considers herself the positive mix of a European-American medical-scientific training having provided her with the background and expertise needed for carrying out sound, methodologically valid, yet innovative epidemiologic research, which she then translates to policy making individuals and institutions. Her major goal is to contribute to the inspiration and formation of future generations of scientists, including her own children. She is the author of more than 400 publications including 127 listed in Medline and has numerous editorial activities for several peer-reviewed journals. She is currently the member of many expert committees, scientific and other boards, as well as civil societies groups. She is cofounder and Vice President of the European Society of Environmental Health. In 2005, she was of the 1000 women nominated for the Peace Nobel Prize. A true citizen of the world, she speaks and works in French, English, and Italian, with notions of German and Spanish.

Biography Updated on 22 August 2007

Personal Home Page

http://www.wcbcf.ca/sasco08.php

Articles in Scholarly Journals [Incomplete List]

  1. Cancer and globalization?
    Biomedicine & Pharmacotherapy, vol. 62, no. 2, pp. 110–121, 2008
  2. Regulation of smokeless tobacco products
    The Lancet, vol. 371, no. 9623, pp. 1504–1504, 2008
  3. Aberrant DNA Methylation of P16, MGMT, and hMLH1 Genes in Combination with MTHFR C677T Genetic Polymorphism in Esophageal Squamous Cell Carcinoma
    Cancer Epidemiology Biomarkers & Prevention, vol. 17, no. 1, pp. 118–125, 2008
  4. The need to develop centers for environmental oncology
    Biomedicine & Pharmacotherapy, vol. 61, no. 10, pp. 614–622, 2007
  5. Personal care products that contain estrogens or xenoestrogens may increase breast cancer risk
    Medical Hypotheses, vol. 68, no. 4, pp. 756–766, 2007
  6. The multitude and diversity of environmental carcinogens
    Environmental Research, vol. 105, no. 3, pp. 414–429, 2007
  7. Cancer, environnement et populations à l’heure de la mondialisation
    Oncologie, vol. 9, no. 5, pp. 380–391, 2007
  8. Lung Cancer Risk and Workplace Exposure to Environmental Tobacco Smoke
    American Journal of Public Health, vol. 97, no. 3, pp. 545–551, 2007
  9. Aspects of Digestive Tract Tumors in Down Syndrome: A Literature Review
    Digestive Diseases and Sciences, vol. 51, no. 11, pp. 2053–2061, 2006
  10. An ovarian dysgerminoma in Down syndrome. Hypothesis about the association
    International Journal of Gynecological Cancer, vol. 16, no. s1, pp. 375–379, 2006
  11. Association between biomarkers of environmental exposure and increased risk of breast cancer
    Nature Reviews Cancer, vol. 6, no. 8, Article ID nrc1755-c1, 2006
  12. Worksafe???Innovative Web Technology for Occupational Risk Prevention
    Journal of Occupational and Environmental Medicine, vol. 47, no. 5, pp. 533–534, 2005
  13. Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma
    European Journal of Gastroenterology & Hepatology, vol. 16, no. 12, pp. 1361–1365, 2004
  14. A cohort study of cancer mortality among Biology Research Laboratory workers in The Netherlands
    Cancer Causes & Control, vol. 15, no. 1, pp. 55–66, 2004
  15. Breast Cancer Risk and the Combined Effect of Environmental Estrogens
    Cancer Causes & Control, vol. 15, no. 6, pp. 591–600, 2004
  16. A 23-year-old woman with down syndrome, type 1 neurofibromatosis, and breast carcinoma
    American Journal of Medical Genetics, vol. 125A, no. 1, pp. 94–96, 2004
  17. Tobacco smoking and cancer: a brief review of recent epidemiological evidence
    Lung Cancer, vol. 45, pp. S3–S9, 2004
  18. Survival after proton-beam irradiation of uveal melanomas?
    American Journal of Ophthalmology, vol. 137, no. 6, pp. 1002–1010, 2004
  19. The epidemiology of neonatal tumours
    Pediatric Surgery International, vol. 19, no. 7, pp. 509–519, 2003
  20. Are solid tumours different in children with Down's syndrome?
    International Journal of Cancer, vol. 106, no. 2, pp. 297–298, 2003
  21. Estimating the distribution of lag in the effect of short-term exposures and interventions: adaptation of a non-parametric regression spline model
    Statistics in Medicine, vol. 22, no. 14, pp. 2335–2363, 2003
  22. Occupational risk in health care and research
    American Journal of Industrial Medicine, vol. 43, no. 4, pp. 369–397, 2003
  23. Exposure to chemical carcinogens and risk of cancer among Finnish laboratory workers
    American Journal of Industrial Medicine, vol. 44, no. 4, pp. 343–350, 2003
  24. Cancer Causes and Control, vol. 14, no. 4, pp. 381–389, 2003
  25. Évaluation de la conformité à la réglementation des déclarations d'incidents transfusionnels pour frissons-hyperthermie dans des établissements de santé du sud-est de la France (groupe AIRSEH)Evaluation of adherence to regulation for declaration of notification of febrile non-hemolytic transfusion reactions. A study of the association inter-régionale du sud-est d'hémovigilance (AIRSEH)
    Transfusion Clinique et Biologique, vol. 10, no. 5, pp. 324–330, 2003
  26. Trends in tobacco smoking among adolescents in Lyon, France
    European Journal of Cancer, vol. 39, no. 4, pp. 496–504, 2003
  27. A 22-year French Experience with Solid Tumors in Children with Down Syndrome
    Pediatric Hematology and Oncology, vol. 20, no. 7, pp. 517–529, 2003
  28. Are fetus-in-fetu highly differentiated teratomas? Practical implications
    Pediatrics International, vol. 45, no. 3, pp. 368–368, 2003
  29. Breast Cancer and the Environment
    Hormone Research, vol. 60, no. Suppl. 3, pp. 50–50, 2003
  30. Breast cancer: occurrence, risk factors and hormone metabolism
    Expert Review of Anticancer Therapy, vol. 3, no. 4, pp. 546–562, 2003
  31. Breast screening guidelines should be adapted in Down's syndrome
    BMJ, vol. 324, no. 7346, pp. 1155–1155, 2002
  32. Cancer: the role of extracellular disease
    Medical Hypotheses, vol. 58, no. 4, pp. 340–346, 2002
  33. Cancer Causes and Control, vol. 13, no. 7, pp. 609–616, 2002
  34. Smoking and Its Correlates among Preadolescent Children in France
    Preventive Medicine, vol. 34, no. 2, pp. 226–234, 2002
  35. Aspects of intracranial and spinal tumors in patients with Down syndrome and report of a rapidly progressing Grade 2 astrocytoma
    Cancer, vol. 91, no. 8, pp. 1458–1466, 2001
  36. Frequency of CCR5 gene 32-basepair deletion in Chilean HIV-1 infected and non-infected individuals
    Immunology Letters, vol. 76, no. 2, pp. 115–117, 2001
  37. An infant with Down syndrome and retinoblastoma A possible non-fortuitous association
    Ophthalmic Genetics, vol. 22, no. 2, pp. 117–123, 2001
  38. Journal of Pediatric Hematology/Oncology, vol. 23, no. 5, pp. 331–332, 2001
  39. Veterinary Research Communications, vol. 24, no. 2, pp. 85–102, 2000
  40. Annals of Oncology, vol. 11, no. 3, pp. 355–358, 2000
  41. Cancer risk in laboratory workers: An emphasis on biological research
    American Journal of Industrial Medicine, vol. 38, no. 6, pp. 651–665, 2000
  42. Mortality and cancer incidence in biomedical laboratory personnel in Sweden
    American Journal of Industrial Medicine, vol. 35, no. 4, pp. 382–389, 1999
  43. Why can't we convince the young not to smoke?
    European Journal of Cancer, vol. 35, no. 14, pp. 1933–1940, 1999
  44. UNEXPLAINED INCREASES IN CANCER INCIDENCE IN THE UNITED STATES FROM 1975 TO 1994: Possible Sentinel Health Indicators?1
    Annual Review of Public Health, vol. 20, no. 1, pp. 173–209, 1999
  45. From in utero and childhood exposure to parental smoking to childhood cancer: a possible link and the need for action
    Human & Experimental Toxicology, vol. 18, no. 4, pp. 192–201, 1999
  46. Antenatal therapeutic drug exposure and fetal/neonatal tumours: review of 89 cases
    Paediatric and Perinatal Epidemiology, vol. 12, no. 1, pp. 84–117, 1998
  47. Prognostic factors for mortality in nasopharyngeal cancer: accounting for time-dependence of relative risks
    International Journal of Epidemiology, vol. 27, no. 5, pp. 772–780, 1998
  48. Antenatal therapeutic drug exposure and fetal/neonatal tumours: review of 89 cases
    Paediatric and Perinatal Epidemiology, vol. 12, no. 1, pp. 84–117, 1998
  49. IV.1 Tamoxifen, a human carcinogen or the share of common risk factors?
    European Journal of Cancer, vol. 34, pp. S43–S44, 1998
  50. Another reason to look for tumor suppressor genes on chromosome 21
    Genes, Chromosomes and Cancer, vol. 21, no. 1, pp. 1–1, 1998
  51. Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer
    International Journal of Cancer, vol. 79, no. 3, pp. 278–282, 1998
  52. An excess of testicular germ cell tumors in down's syndrome
    Cancer, vol. 80, no. 5, pp. 929–935, 1997
  53. Response from: I. Rajower, A.J. Sasco and P. Kleihues
    European Journal of Cancer, vol. 33, no. 7, p. 1157, 1997
  54. Antenatal exposure to atenolol and retroperitoneal fibromatosis
    Reproductive Toxicology, vol. 11, no. 4, pp. 539–541, 1997
  55. Incidence of tobacco and alcohol-related cancers in western Europe
    European Journal of Cancer Prevention, vol. 6, no. 6, pp. 560–561, 1997
  56. Breast cancer prognostic significance of some modified urinary nucleosides
    Cancer Letters, vol. 108, no. 2, pp. 157–162, 1996
  57. Tamoxifen and menopausal status: risks and benefits
    The Lancet, vol. 347, no. 9003, p. 761, 1996
  58. Endometrial müllerian carcinosarcoma after cessation of tamoxifen therapy for breast cancer
    International Journal of Gynecology & Obstetrics, vol. 48, no. 3, pp. 307–310, 1995
  59. L'influence de l'age au premier accouchement sur la mortalite par cancer du sein: Une methode d'estimation
    Population (French Edition), vol. 50, no. 3, p. 844, 1995
  60. Review article: Epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors
    International Journal of Cancer, vol. 53, no. 4, pp. 538–549, 1993
  61. Lung cancer: worldwide variation in occurrence and proportion attributable to tobacco use
    Lung Cancer, vol. 9, no. 1-6, pp. 1–16, 1993
  62. Comparative Epidemiology of Cancer
    Epidemiology, vol. 4, no. 5, p. 484, 1993
  63. Cancer risk in laboratory workers
    The Lancet, vol. 339, no. 8794, p. 684, 1992
  64. A systematic survey of breast cancer incidence in the département of Rhône, France
    European Journal of Cancer and Clinical Oncology, vol. 27, no. 12, pp. 1696–1701, 1991
  65. A population-based series of 10 male breast cancer cases
    European Journal of Cancer and Clinical Oncology, vol. 27, no. 12, p. 1713, 1991
  66. World burden of tobacco-related cancer
    The Lancet, vol. 338, no. 8759, pp. 123–124, 1991
  67. Cancer mortality patterns among laboratory workers
    The Lancet, vol. 335, no. 8705, pp. 1597–1598, 1990
  68. LATENT COLORECTAL CANCER FOUND AT NECROPSY
    The Lancet, vol. 333, no. 8650, pp. 1331–1332, 1989
  69. Migrations et cancers*
    La Revue de Médecine Interne, vol. 10, no. 4, pp. 341–348, 1989
  70. Response Etiologic and prevented fraction in case-control studies of screening
    Journal of Clinical Epidemiology, vol. 41, no. 8, pp. 809–811, 1988
  71. Response Etiologic fraction in case-control studies for the evaluation of screening
    Journal of Chronic Diseases, vol. 40, no. 4, p. 368, 1987
  72. PREVALENCE OF GASTRIC CANCER IN A LARGE NECROPSY SERIES
    The Lancet, vol. 327, no. 8481, p. 624, 1986
  73. Current hypotheses on the etiology of colorectal cancer critical review of the epidemiological evidence
    Sozial- und Präventivmedizin SPM, vol. 31, no. 2, pp. 78–80, 1986
  74. Case-control studies for the evaluation of screening
    Journal of Chronic Diseases, vol. 39, no. 5, pp. 399–405, 1986